Previous close | 4.0800 |
Open | 4.1400 |
Bid | 3.9100 x 4200 |
Ask | 3.9700 x 4500 |
Day's range | 3.8400 - 4.2000 |
52-week range | 1.6400 - 4.3000 |
Volume | |
Avg. volume | 13,421,239 |
Market cap | 2.326B |
Beta (5Y monthly) | 0.61 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Geron (GERN) delivered earnings and revenue surprises of 10% and 102.67%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
We feel now is a pretty good time to analyse Geron Corporation's ( NASDAQ:GERN ) business as it appears the company may...
Geron Corporation (GERN) and Crinetics Pharmaceuticals (CRNX) gain on positive regulatory and study updates.